A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities (2019)
Attributed to:
MICA: Characterisation of a novel bromodomain inhibitor AZD5153 in castrate resistant prostate cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/nar/gkz286
PubMed Identifier: 31006810
Publication URI: http://europepmc.org/abstract/MED/31006810
Type: Journal Article/Review
Parent Publication: Nucleic Acids Research
Issue: 11
ISSN: 0305-1048